Financial Statements · Financial Reporting
UAB "Novo Nordisk Pharma"
Official identifier 300114028Record date 31 Dec 2023
LithuaniaFinancial metrics
| Metric | Value |
|---|---|
| Profit / loss before tax | 912,567 |
| Net profit / loss | 752,671 |
| Sales revenue | 21,820,183 |
Linked company
Company: UAB "Novo Nordisk Pharma"